Drug Profile
GSK 1247303
Alternative Names: 1247303; S-247303Latest Information Update: 06 Nov 2012
Price :
$50
*
At a glance
- Originator Shionogi - GlaxoSmithKline (JV)
- Developer ViiV Healthcare
- Class Antiretrovirals
- Mechanism of Action HIV integrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 06 Nov 2012 No development reported - Phase-II for HIV infections in USA (PO)
- 31 Oct 2012 ViiV Healthcare acquires exclusive global rights to the assets of the joint venture Shionogi-ViiV Healthcare LLC, including HIV integrase inhibitors
- 01 Jul 2010 Phase-II clinical trials in HIV infections in USA (PO)